elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35674875-70DF34C0-156B-4AD0-ACA4-31AAC4AFF025
Q35674875-70DF34C0-156B-4AD0-ACA4-31AAC4AFF025
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674875-70DF34C0-156B-4AD0-ACA4-31AAC4AFF025
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.
P2860
Q35674875-70DF34C0-156B-4AD0-ACA4-31AAC4AFF025
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674875-70DF34C0-156B-4AD0-ACA4-31AAC4AFF025
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51622c216d598bf6255068b4675d8f501f698f4f
P2860
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.